newsfilter
← Latest News
Business Wire·

Vir Biotechnology Announces Chief Financial Officer Transition

Vir Biotechnology, Inc. (NASDAQ:VIR) today announced that Brent Sabatini, Senior Vice President and Chief Accounting Officer, has been appointed Interim Principal Financial Officer, effective July 23. Jason O’Byrne is